Chemiluminescence Immunoassay (CLIA) Dominance in Japanese Clinical...

added blog Other

2025-08-07 13:12:29 -

Chemiluminescence Immunoassay (CLIA) Dominance in Japanese Clinical Laboratories

The Japan immunoassay market, valued at USD 1.52 billion in 2024 and expected to grow at a CAGR of 5.5% through 2034, is undergoing a structural evolution driven by innovation in product segmentation and shifting clinical demands. Growth is increasingly concentrated in high-performance assay categories such as chemiluminescence immunoassays (CLIA), enzyme-linked immunosorbent assays (ELISA),...

0 Comments 0 Shares 72 Views 0 Reviews